Sign in to view content

Suprachoroidal Delivery of RGX-314 for Diabetic Retinopathy Without CI-DME: Early Results From the Phase II ALTITUDE Study

Dennis M. Marcus, MD

Video
Published 2021

Related

Suprachoroidal CLS-AX (axitinib injectable suspension), as a Potential Long-Acting Therapy for Neovascular Age-Related Macular Degeneration (nAMD)
David M. Brown, MD
Annual Meeting Talks
2020
Comparison of CRISPR-based Genome Editing of VEGF-A as Treatment Strategy for Choroidal Neovascularization
Glenn C. Yiu, MD, PhD
Updates from the Field
2019
Episode 201: AMD Drug Updates with Dr. Allen Ho, including Gene Therapy
Jayanth Sridhar, MD
Member Podcasts
2019

Category: Diabetic Retinopathy

See more